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Background: The high mobility group (HMG) family transcription factor Sox9 is critical for induction and
maintenance of neural stem cell pool in the central nervous system (CNS). In the spinal cord and retina, Sox9 is also
the master regulator that defines glial fate choice by mediating the neurogenic-to-gliogenic fate switch. On the
other hand, the genetic repertoire governing the maintenance and fate decision of neural progenitor pool in the
cerebellum has remained elusive.
Results: By employing the Cre/loxP strategy, we specifically inactivated Sox9 in the mouse cerebellum. Unexpectedly, the
self-renewal capacity and multipotency of neural progenitors at the cerebellar ventricular zone (VZ) were not perturbed
upon Sox9 ablation. Instead, the mutants exhibited an increased number of VZ-derived neurons including Purkinje cells
and GABAergic interneurons. Simultaneously, we observed continuous neurogenesis from Sox9-null VZ at late gestation,
when normally neurogenesis ceases to occur and gives way for gliogenesis. Surprisingly, glial cell specification was not
affected upon Sox9 ablation.
Conclusion: Our findings suggest Sox9 may mediate the neurogenic-to-gliogenic fate switch in mouse cerebellum by
modulating the termination of neurogenesis, and therefore indicate a functional discrepancy of Sox9 between the
development of cerebellum and other major neural tissues.
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During vertebrate CNS development, the radial glial cells
are self-renewing multipotent neural stem cells that gener-
ate the major differentiated cell types in the mature brain,
including neurons, myelin-forming oligodendrocytes and
non-myelinating astrocytes [1]. To construct the remark-
able cellular diversity in the CNS, cell fate decisions must
be orchestrated by sophisticated networks of signaling
molecules and transcription factors; while the combina-
torial effects of which tightly regulate cell lineage speci-
fication and differentiation within the neural progenitor
pool in a spatial-temporal manner. Any defects during
the developmental process are therefore detrimental
and can lead to various neurological and psychiatric
disorders [2,3].* Correspondence: kmkwan@cuhk.edu.hk
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unless otherwise stated.In the developing cerebellum, radial glial-like neural
progenitors at the ventricular zone (VZ) are capable of
generating the entire repertoire of GABAergic neuronal
subtypes and glial cells [4]. Since the onset of cerebellar
neurogenesis at embryonic day 10.5 (E10.5), GABAergic
neurons including Purkinje cells and deep cerebellar nu-
clei neurons are produced from the VZ by asymmetric,
neurogenic division of radial glial cells and become ter-
minally differentiated [5], whilst neuronal progenitors
committed to inhibitory interneurons delaminate from
the VZ and continue to proliferate within the prospect-
ive white matter (PWM) until after birth [6,7]. During
these initial progressive waves of neurogenesis the VZ
generates very few, if any, glial populations. Towards late
gestation, however, neurogenesis in the cerebellar VZ
progenitor pool gradually ceases and is taken over by the
production of oligodendrocytes and astrocytes [8]. In-
deed, this sequential production of neurons and glia
from the VZ neuroepithelium is not a phenomenon
unique to the cerebellum, but is rather a process funda-
mental to the entire developing CNS and is conservedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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relatively well characterized molecular events leading to
stem cell fate decision in the neocortex and spinal cord,
analogous mechanisms in the cerebellum that govern
the induction of stem cell characteristics and neurogenic
to gliogenic fate switch thus the commitment to gliogen-
esis have remained unclear.
Sox9 belongs to the SoxE subgroup of the highly con-
served family of high mobility group (HMG) transcrip-
tion factors. Over the past two decades, Sox9 has been
shown to govern developmental activities and was impli-
cated in the maintenance of stem cell pool in a wide
array of tissues such as testes, pancreas, heart and the
skeleton, among others [13,14]. Importantly, genetic
analyses of different models have shown that Sox9 is
vital in triggering the switch from neurogenic to glio-
genic program at the germinal zones of different neural
tissues [10,12]. In the absence of Sox9, the spinal cord
exhibited a transient increase in the number of motor
neurons at the expense of the astroglial progenitor
population [12], while mosaic depletion of Sox9 in the
developing mouse retina resulted in agenesis of the
Müller glial cells [10]. Noteworthily, Sox9 expression in
the neural stem cells at different regions of the CNS was
demarcated for a long time. But it is only until recently,
Sox9 was demonstrated to be indispensable for the es-
tablishment and maintenance of neural stem cells in
both embryonic and adult CNS [15,16]. In developing
cerebellum, Sox9 is expressed specifically along the VZ
where the radial glial cells populate. Given the import-
ance of Sox9 in several critical aspects of CNS develop-
ment and that its expression in the cerebellum coincides
with robust neurogenic activities, we sought to deter-
mine whether Sox9 is involved in the establishment and
maintenance of neural progenitor identity and charac-
teristic, as well as the initiation of gliogenesis in the
cerebellum.
Here in this study, using the Cre/loxP recombination
approach, we specifically ablated Sox9 expression in the
cerebellum by employing a Sox9 conditional (floxed) al-
lele together with either the Engrailed1 (En1)-Cre or
Paired box 2 (Pax2)-Cre allele. Surprisingly, self-renewal
capacity of the VZ progenitors was not abolished upon
Sox9 inactivation. Meanwhile, initial neurogenesis at nei-
ther cerebellar VZ nor the anterior rhombic lip was not
perturbed despite robust Sox9 expression at these two
cerebellar germination zones. Interestingly, generation of
Purkinje cells and GABAergic interneurons from the VZ
of Sox9-null cerebellum increased remarkably was ob-
served in the Sox9 null cerebellum, the surplus of which
probably arise at late gestation when normally neurogen-
esis should decline. To our surprise, specification of the
glial lineage appeared normal in our Sox9 mutants. These
findings suggest that Sox9 is dispensable for neural stemcell activity and defining the glial fate of these progenitors
in the embryonic cerebellum, in contrast to our current
understanding of Sox9 function in other regions of the
CNS. However, our data suggests a critical role of Sox9 in
termination of neurogenesis and mediating the complete
neurogenic-to-gliogenic fate switch of cerebellar neural
progenitors.Results
Sox9 expression in the neural progenitors and glial
lineage of cerebellum
To understand the role of Sox9 in cerebellar neural
progenitor cell fate specification and differentiation, we
first performed a detailed analysis of Sox9 protein ex-
pression profile during embryonic cerebellar develop-
ment in mouse. Shortly after neural tube closure and
formation of the pontine flexure, the cerebellar primor-
dium is established from rhombomere 1 of the hind-
brain between embryonic day (E) 9.5 and E11.5, when
the two primary germination zones of cerebellum, the
VZ and the anterior rhombic lip (RL) are compartmen-
talized [17]. Consistent with previous studies in the tel-
encephalon [16], we did not detect any Sox9 expression
in the cerebellum before E10.5 (data not shown). At
E11.5 however, Sox9 became readily detectable
throughout the cerebellar primordium (Figure 1A).
Double immunohistochemistry was performed and the
vast majority of Sox9 expression in the two cerebellar
germination zones coincided with that of Sox2, a
marker for actively proliferating neural stem cells and
progenitors [18] (Figure 1A’). From E13.5 onwards,
Sox9 became restricted to the VZ neuroepithelium
(Figure 1B). Thereafter, we still observed close associ-
ation of Sox9 expression with that of Sox2 (Figure 1B’),
while robust expression of Sox9 persisted at the VZ
throughout gestation. From E15.5 onwards, some of the
Sox9-expressing cells had delaminated from the VZ
and were migrating upwards radially towards the pre-
sumptive cerebellar cortex (Figure 1C and C’). During
cerebellum development, Sox9-expressing cells at the
VZ were also immunoreactive for the excitatory amino
acid transporter EAAT1 [19] which is an attribute sug-
gestive of the multipotent radial glial cells (Figure 1D).
By E18.5, Sox9 expression was detected in the nascent
Purkinje cell layer (PCL) where they co-localized with
EAAT1, a marker for the differentiated astrocytic
lineage at late embryonic stages. On the other hand,
Sox9+ cells scattered throughout the prospective white
matter (PWM) (Figure 1E). By P5, as the VZ neuroepi-
thelium gradually diminished, Sox9-expressing cells be-
came predominantly situated in the PCL where they
also expressed the Bergmann glia-specific glial fibrillary
acidic protein (GFAP) consistently (Figure 1F).
Figure 1 Sox9 expression coincides with markers for neural progenitors, RGCs and Bergmann glia during mouse cerebellum development as
revealed by immunofluorescence staining of cerebellar sagittal sections from E11.5 to P5. (A, A’) At E11.5, Sox9 immunoreactivity could be
observed in the entire cerebellar primordium, covering the newly specified VZ and RL. (B, B’) At E13.5, Sox9 expression became restricted to the
VZ, while traces of Sox9+ cells were also found in the RL. (C, C’) Sox9 expression persisted throughout gestation at the VZ. From E15.5 onwards,
Sox9 could also be detected in cells that had delaminated from the VZ as they migrate to the Purkinje cell plate at E18.5. (A’-C’) Magnified view
of the corresponding VZ region marked by dotted square in A-C. Almost all the Sox9 expressing cells were immmunoreactive for the neural stem
cell marker Sox2 throughout the embryonic cerebellum development. (D and E) Co-localization of Sox9 with the glial marker was observed from
E13.5 to E18.5. (D’) At E13.5, EAAT1 was predominantly localized to the VZ where the Sox9+ radial glial cells reside. (E’) After the onset of
astrogliogenesis, the majority of EAAT1 expression at E18.5 was found at the PCL where the Bergmann glial cells locate. (F and F’) By P5, Sox9
signal was found predominantly at the PCL, where it labeled the soma of GFAP+ Bergmann glial cells. Abbreviations: egl, external granular layer;
igl, internal granular layer; pcl, Purkinje cell layer; ml, molecular layer; rl, rhombic lip; vz, ventricular zone. Scale bars: A-F, 100 μm; A’-F’, 50 μm.
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Having observed that Sox9 was robustly expressed in the
neural progenitors and differentiated glial cells through-
out cerebellum development, we hypothesized that Sox9
may regulate the cerebellar neural progenitor pool and
their fate commitment to gliogenesis. To address the
role of Sox9 during cerebellum development, Sox9 loss-
of-function analysis in the mouse cerebellum was per-
formed. To circumvent the early embryonic lethality
owing to cardiac neural crest defects [20] that precludes
the assessment of cerebellum development, we employed
En1 or Pax2 driven Cre, both of which possess robust ac-
tivity at the mid-hindbrain boundary of the early neuraltube to ensure a complete knockout of Sox9 in the cere-
bellum [21-23]. Conditional knockout of Sox9 driven by
either En1-Cre or Pax2-Cre resulted in lethality very
shortly after birth (Figure 2A and B). Conditional inactiva-
tion of Sox9 with En1-Cre in the cerebellum did not affect
the morphological criteria of cerebellar development as
revealed by general histological examination with
hematoxylin and eosin (H & E) staining (Figure 2C and
D). However, Sox9 deletion mediated by Pax2-Cre re-
sulted in improper or obscure cerebellar foliation no-
ticeable from E16.5 onwards, the severity of which was
variable between litters (Figure 2G and H). In these
mutants, Cre expression in the cerebellar primordium
Figure 2 En1-Cre and Pax2-Cre mediated inactivation of Sox9 in
mouse cerebellum. (A and B) Conditional knockout of Sox9 driven
by either En1-Cre or Pax2-Cre resulted in lethality at birth. Gross
morphology of E18.5 embryos comparing the control and Sox9
mutants displayed. (C and D) H&E-stained cerebellar sagittal sections
showing no alterations in morphological criteria of the cerebellum
upon En1-Cre mediated Sox9 inactivation, despite efficient ablation of
Sox9 expression in the mutant cerebellum as shown by the
immunohistochemical staining detecting Sox9 indicated in (E and F).
Strong expression of Sox9 could be observed in the control along the
VZ at E15.5 while the mutant cerebellum lacked any Sox9
immunoreactivity. (G and H) Defect in cerebellar foliations was
observed at E18.5 in the Pax2-Cre Sox9 mutant. (I and J) The fidelity of
Pax2-Cre mediated Sox9 inactivation was validated by the complete
absence of Sox9 expression in the mutant cerebellum. (K) Upon
ablation of Sox9 using Pax2-Cre, no significant up-regulation of the
closely related SoxE family member Sox10 transcript expression level
was observed in the mutant using quantitative real-time PCR (p =
0.1617). The error bars indicate standard deviations. Abbreviations: vz,
ventricular zone;. Scale bars: A and B: 1 cm; C-J: 100 μm.
Vong et al. Molecular Brain  (2015) 8:25 Page 4 of 17efficiently ablated Sox9 in all cerebellar cells and their
derivatives, as evident by PCR analysis with cerebellar
genomic DNA (data not shown) and the complete ab-
sence of Sox9 immunoreactivity in the cerebellum of
the Sox9 mutants at all developmental stages being in-
vestigated, thus confirming the fidelity of En1-Cre and
Pax2-Cre mediated functional inactivation of Sox9
(Figure 2E,F,I and J). Sox8 and Sox10, the other mem-
bers of the SoxE family, are also expressed in the radial
glia, astrocytes and oligodendrocyte progenitors of the
CNS [24]. Given that Sox8 or Sox10 can partially com-
pensate for the loss of Sox9 in the spinal cord and tel-
encephalon respectively [12,16], the expression of Sox8
and Sox10 in our Sox9 mutants was also examined.
Sox8 transcripts were not detected in the cerebellum
(data not shown) while Sox10 transcripts were only
scarcely expressed as compared to Sox9 mRNA expres-
sion. Nonetheless, Sox10 mRNA expression was not
up-regulated in Sox9 null cerebellum as indicated by
quantitative real-time PCR (Figure 2K).
Sox9 was dispensable for self-renewal capacity of cerebel-
lar neural progenitors
To determine whether the neural stem cell identity of
the VZ neural progenitors was perturbed upon Sox9 ab-
lation, expression pattern of the neural stem cell marker
Sox2 was examined by immunostaining. Interestingly,
Sox2 expression was retained in the VZ and PWM of
the Sox9-null cerebellum even at late gestation period
between E16.5 and E18.5 (Figure 3A-D). We then asked
whether the self-renewal capacity of the VZ neural pro-
genitors was abrogated in the Sox9 mutants. To assess
the mitotic index of VZ progenitors, bromodeoxyuridine
(BrdU) incorporation efficiency was examined. Pregnant
female mice at E16.5 or E18.5 of gestation were injected
Figure 3 Self-renewal of neural progenitors in cerebellum was not abrogated upon Sox9 inactivation as revealed by immunofluorescence
staining on cerebellar sagittal sections. (A-D) Expression of the neural stem cell marker Sox2 was not lost in the Sox9-null cerebellum during late
gestation under both En1-Cre and Pax2-Cre mediated Sox9 inactivation. In both groups, scattered signals were observed in the VZ and the
prospective white matter, while the EGL displayed the strongest signal which corresponded to the actively proliferating granule cell precursors.
(A’) and (B’) showed enlarged view of the VZ. (E-J) Quantification of mitotic activity at the VZ by double pulses of BrdU at either E16.5 (E-F) or
E18.5 (G-H) did not reveal any difference in the proliferation of VZ neural progenitors between control and the Pax2-Cre induced Sox9-null
mutant. The number of BrdU-labeled cells in the VZ was divided by the total number of VZ cells to obtain the labeling index (I-J). No statistically
significant difference was observed using the Student’s t-test at both E16.5 (I; p = 0.4906) and E18.5 (J; p = 0.1633). (K-R) In addition, we did not
observe any alterations in the expression of proliferation associated markers PCNA and Ki67 upon Sox9 inactivation. (A’-Q’) are the enlarged view
at the VZ of (A-Q). The error bars indicate standard deviations. Abbreviations: egl, external granular layer; pcl, Purkinje cell layer; rl, rhombic lip; vz,
ventricular zone. Scale bars: A-S: 100 μm; A’-B’, G’-H’, K’-L’, P’-Q’: 50 μm.
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We did not observe any statistically significant difference
in the proportion of BrdU incorporated neural stem cells
within VZ of controls and Sox9 mutants at both stages,
while the spatial distribution of BrdU+ cells in Sox9-null
cerebellum also appeared normal (Figure 3E-J). In
addition, expression of the proliferating cell nuclear anti-
gen (PCNA) and Ki67 which denotes mitotic activity in
the Sox9 mutant cerebella were not impaired as well
throughout the course of cerebellar development
(Figure 3K-R). We also examined the possibility that loss
of Sox9 may lead to increased programmed cell death in
the mutant VZ by detecting cleaved caspase 3 signals, a
hallmark for apoptosis, by immunostaining. Again, few
cells positive for cleaved caspase 3 was observed in the
WT or Sox9-null cerebellum, indicating that no apop-
totic activity among the cerebellar progenitors was up-regulated upon Sox9 inactivation (data not shown). To-
gether, these data suggest that Sox9 is not a critical regu-
lator that governs the self-renewal and survival of neural
progenitors in the developing cerebellum.
Sox9 was not required for the neuronal differentiation of
cerebellar progenitors
Previous studies in forebrain have suggested that Sox9 is
critical for differentiation of neural stem cells into ma-
ture neurons as evident by a drastic loss of Tuj1 expres-
sion in the dorsal telencephalon and spinal cord of the
Sox9 mutant [16]. We therefore assessed the multipo-
tency of Sox9-null VZ progenitors in generating different
neuronal subtypes. Multipotent RGC-like progenitors in
the VZ give rise to all the inhibitory neurons in the cere-
bellum including Purkinje cells (PCs) and GABAergic
interneurons [25]. PCs are recognized by the expression
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[26], the calcium-binding protein Calbindin D-28K [27],
or the forkhead domain transcription factor Foxp2 at
late embryonic stage [28]. On the other hand, the paired
box transcription factor Pax2, labels postmitotic
GABAergic interneurons or their progenitors undergo-
ing the final mitotic cycle [7]. Unexpectedly, immuno-
staining at E16.5 revealed no significant difference in
neurogenesis of either PCs or GABAergic interneurons
(E and J), in both the control and Sox9 mutant cerebella
as exemplified by the normal expression pattern of both
Lhx1 (Figure 4A-D) and Pax2 (Figure 4F-I). Similarly,
the loss of Sox9 had no observable effect on the generalFigure 4 Cerebellar neural stem cell multipotency was not abolished in So
inactivation as shown by immunofluorescence staining on cerebellar sagitt
including Purkinje cells (PCs) and GABAergic interneurons was observed, as
interneurons (F-I) between control and Sox9 mutant cerebella at E16.5. Bot
in the Sox9 mutants (E; p = 0.6870 and J; p = 0.9980). (K-S) Specification of
also normal, as exemplified by robust expression of Pax6 at the EGL. The d
that the multipotency of neural stem cells in cerebellum was retained upo
prospective white matter; vz, ventricular zone. Scale bar: 100 μm.localization and differentiation of RL derivatives, includ-
ing the Pax6-expressing excitatory granule cells
(Figure 4K-S), despite Sox9 expression in the RL progen-
itors during the phase of granule cell specification.
These results support that, unlike in the dorsal telen-
cephalon, subventricular zone as well as the spinal cord
[12,16], Sox9 is dispensable for the maintenance of
neural progenitor multipotency in the cerebellum.
Prolonged and enhanced neurogenesis in the Sox9-null
cerebellum
Having observed no significant decrease in the mitotic
activity among the VZ progenitors upon Sox9 ablation,x9-null cerebellum under both En1-Cre and Pax2-Cre mediated Sox9
al sections. (A-D, F-I) No defects in the neurogenesis of VZ-derivatives
indicated by the normal distribution of Lhx1+ PCs (A-D) and Pax2+
h the number of Lhx1+ PCs and Pax2+ interneurons appeared normal
the RL-derived progenitors committed to become granule cells was
ifferentiation of progenitors into different neuronal subtypes suggests
n Sox9 inactivation. Abbreviations: egl, external granular layer; pwm,
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the VZ was defective. Postmitotic PCs are generated
from VZ between E11.5 and E13.5, and subsequently mi-
grate along the radial glial fiber to form the Purkinje cell
layer (PCL) where they undergo extensive morphological
remodeling [29,30]. Shortly before birth at E18.5, the
Sox9 mutant cerebellum exhibited an expanded expres-
sion domain of Calbindin localized ectopically close to
the VZ, in addition to its normal expression at the PCL
(Figure 5A-B). This leads to our speculation that neuro-
genesis for PCs was enhanced upon Sox9 knockout.
Since Calbindin is a cytoplasmic protein and renders val-
idation of this hypothesis difficult, we therefore analyzed
PCs generation by quantifying Foxp2-expressing cells at
E18.5. While Foxp2 immunoreactivity was observed pre-
dominantly in the PCL of the control, many ectopic
Foxp2-expressing cells could be found in the vicinity of
the VZ in the Sox9-null cerebellum, faithfully recapitu-
lating the expression pattern of Calbindin (Figure 5C-D).
A 1.3 fold increase in the total number of Foxp2-
expressing cells was observed in the mutant cerebellum
(p < 0.0001), most of which was contributed by an in-
crease in the Foxp2-expressing cells outside the PCL
(Figure 5G). We then determined whether the increased
neurogenesis at VZ was consistent throughout differentFigure 5 Increased neurogenesis of VZ-derivatives in Sox9-null cerebellum.
showed an up-regulation of Calbindin expression in the Sox9 mutant with
Foxp2+ cells could be found in the Sox9 mutant cerebellum and the spatia
Calbindin (compared with B). (G) Quantification of Foxp2+ cells confirmed
was predominantly localized outside the PCL at the vicinity of VZ. (E, F and
30% in the Sox9-null cerebellum than in the control. Asterisks (***) indicate
t-test. The error bars indicate standard deviations. Abbreviations: egl, externneuronal subtypes. Quantification of Pax2-expressing
cells also revealed a 1.3 fold increase (p < 0.0001) in the
total number of postmitotic GABAergic interneurons in
the Sox9-null cerebellum (Figure 5E,F and H). Taken to-
gether, the ablation of Sox9 in the cerebellum in vivo did
not perturb the initial generation of PCs and GABAergic
interneurons. Instead, Sox9 inactivation led to markedly
increased neurogenesis from the VZ and subsequently a
remarkably enhanced number of these inhibitory neurons.
In contrast to PCs which are postmitotic upon migra-
tion from the VZ, GABAergic interneuron progenitors
are still proliferative upon delamination from the VZ
and subsequently populate a secondary germinal site
known as the prospective white matter (PWM) which is
active throughout late embryonic and early postnatal de-
velopment [7]. We therefore questioned whether the
surplus of Pax2-expressing cells was a consequence of
enhanced proliferating activity within the PWM. To clar-
ify this point, embryos were pulsed with BrdU 30 min
prior to sacrifice, and mitotic activity at the PWM was
quantified by counting BrdU-labeled cells within the
Pax2-expressing domain in the cerebellar cortex. Our re-
sults, however, indicated that proliferation at the PWM
was reduced by about 35% in the Sox9-null cerebellum
(p = 0.0012) (Figure 6A,B and G), which was also evident(A-B) Immunofluorescence staining on cerebellar sagittal sections
an ectopic expression domain close to the VZ (arrows). (C-D) More
l distribution of which closely mimicked the expression pattern of
a 1.3 fold increase in the Purkinje cell populations, the surplus of which
H) The number of Pax2-expressing cells was also increased by about
statistically significant difference of p-value < 0.0001 by the Student’s
al granular layer; vz, ventricular zone. Scale bars: A-C: 100 μm.
Figure 6 (See legend on next page.)
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Figure 6 Increased neuronal populations due to prolonged neurogenesis at the VZ as revealed by immunofluorescence staining on cerebellar
sagittal sections. (A, B) Becoming active since late gestation, the prospective white matter (PWM) (dotted area) is where interneuron progenitors
delaminated from the VZ proliferate, gradually fate restricted and become postmitotic. The identity of PWM as a secondary germinal site in the
developing cerebellum was exemplified by identifying the BrdU positive cells within the Pax2 positive domain. (G) Proliferation within the PWM
at E16.5 was reduced in Sox9-null cerebellum when compared with control (***, p < 0.005). (C, D and H) BrdU tracing experiments from E13.5 to
E18.5 revealed no difference in the number of Pax2+ interneurons born at around E13.5 between controls and mutants. (E, F and I) In contrast,
BrdU tracing experiments from E16.5 to E18.5 showed significantly more interneurons were born at around E16.5, as evident by increased
number of double Pax2+ BrdU+ cells localized at the proximity of VZ in Sox9 mutant cerebellum (E’ and F’, arrows) (*, p < 0.05). (J, K and L) Ngn2
expression level was more than 1.3 fold higher in E16.5 Sox9 mutant cerebellum (**, p < 0.01), while that of Ascl1 and Ngn1 was not significantly
different between controls and mutants (p = 0.9072 and p = 0.3896 respectively). E’ and F’ are magnified view of the area enclosed by inset in E
and F. Abbreviations: egl, external granular layer; n.s., not statistically significant; vz, ventricular zone. The error bars indicate standard deviations.
Scale bar: 100 μm.
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within the PWM in Sox9-null cerebellum (Figure 3K-R).
Thus, the increased neurogenesis of Pax2+ interneurons
observed is unlikely due to enhanced proliferative activ-
ity at the secondary germinal zone. To determine the
birthdate of the surplus of postmitotic Pax2-expressing
interneurons found in Sox9-null cerebellum at E18.5,
control and mutant embryos were pulsed with BrdU at
E13.5 or E16.5 and sacrificed at E18.5. In the 5-days
BrdU tracing, the number of Pax2/BrdU double positive
cells found in control or mutant cerebellum was similar,
suggesting that the extent in the generation of GABAer-
gic interneurons at around E13.5 was not significantly
up-regulated in the Sox9 mutants (Figure 6C, D and H).
In contrast, the number of cerebellar Pax2-expressing
cells born at E16.5 was about 60% more in Sox9-null
cerebellum compared with the control (Figure 6E, F
and I). Since we did not observe any increase in prolifera-
tive activity at the PWM, our data therefore suggested that
neurogenesis at the VZ after E16 was significantly en-
hanced upon knockout of Sox9 in cerebellum. Notably,
the majority of Pax2-positive interneurons born at
E16.5 in Sox9 mutants were clustered at the vicinity of
VZ, further suggesting that the surplus of GABAergic
interneurons were originated from the cerebellar VZ,
instead of being the descendants of progenitors within
the PWM (Figure 6E’ and F’). The expression of pro-
neural genes at E16.5, when normally the neurogenic-
to-gliogenic fate switch is occurring in the cerebellum,
was examined by quantitative RT-PCR. The bHLH
transcription factor Ngn2 mRNA was up-regulated
by around 30% in the Sox9-null cerebellum (n = 6,
p = 0.0070) (Figure 6L); while Ascl1 and Ngn1 expression
level in Sox9 mutants did not differ from the controls
significantly (Figure 6J and K).
Glial fate determination in the cerebellum was not
impaired upon loss of Sox9
The increase in neuronal population in Sox9 mutant
cerebellum as a consequence of extended neurogenesis
during late gestation prompted us to examine whetherthis phenotype occurred at the expense of gliogenesis
which commences during this developmental window.
We first studied expression of the oligodendrocyte
marker Olig2 and astrocytic marker S100 by quantitative
PCR. To our surprise, neither of their expression was
significantly diminished in Sox9 mutants (Figure 7J) We
then analyzed the expression of the glial-specific brain
lipid-binding protein (BLBP) in histological sections of
the control and Sox9 CKO mutant cerebella. At E13.5,
widespread expression of BLBP could be observed at the
VZ and its vicinity in both the control and Sox9 mutant
(Figure 7B-C). Unexpectedly, though at E18.5, strong ex-
pression of BLBP persisted in both the control and Sox9-
null cerebellum (Figure 7D-I). BLBP signal could be
detected along the entire medial-to-lateral (vermal-to-
hemispherical) axis in coronal cerebellar sections of both
the controls and mutants, consistent with the observa-
tion described above (Figure 7D-E). Robust immunore-
activity for BLBP corresponding to the soma of radial
glial cells was also observed in the VZ throughout cere-
bellum development (Figure 7F’, G’, H’ and I’), further
supporting the intactness of the neural stem cell pool
even upon loss of Sox9 in the mutant cerebellum. At this
stage, BLBP was also expressed by precursors of the
Bergmann glia (BGs) which are cerebellum-specific as-
trocytes intermingled among the PCs and have the glial
processes extending through the molecular layer (ML)
with the endfeet terminating at the pial surface [31]. In
both the control and Sox9 mutant cerebellum, distinctive
BLBP expression could be observed in the PCL and at
the pial surface, indicating the correct specification of
BG identity in the absence of Sox9 (Figure 7F”, G” H”
and I”). The general orientation of the glial process ar-
rangement was also not perturbed in the Sox9 null cere-
bellum. In addition, glial cells express membrane-bound
excitatory amino acid transporters (aka glutamate trans-
porters) to terminate excitatory synaptic transmission by
removal or uptake of glutamate from neuronal synapses
[32]. In the cerebellum, the excitatory amino acid trans-
porter EAAT1 or GLAST is expressed specifically in the
radial glial cells or later in the BGs surrounding the
Figure 7 (See legend on next page.)
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Figure 7 Bergmann glia specification was not abolished in Sox9-null cerebellum. (A) Real-time PCR of the oligodendrocyte marker Olig2 and
astrocyte marker S100 showed that gliogenesis was not perturbed in Sox9 mutant (p = 0.2764 and p = 0.7551 respectively). (B-C) At E13.5, BLBP ex-
pression that marked the early-born radial glial cells which function as the cerebella neural stem cell pool, spanning the entire VZ in both the
control and Sox9 mutant. Expression of BLBP persisted in the cerebellum throughout embryonic development as indicated by both coronal sec-
tions (D-E) and sagittal sections (F-I). (F’-I’) Particularly strong BLBP signal in the VZ where soma of radial glia resides was seen in both control
and mutant cerebella. Filamentous BLBP immunoreactivity of the glial scaffold was not disrupted in the Sox9-null cerebellum. (F”-I”) Robust BLBP
expression representing prospective Bergmann glia could be observed in the PCL of Sox9 mutants (broken line), with the glial endfeet which ter-
minated at the pial surface equally conspicuous in the control and Sox9 mutant.
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the transdifferentiation of radial glia into BGs was yet initi-
ated, EAAT1 expression was predominantly localized in
the VZ and along the radial glial scaffold in the control
cerebellar cortex and was not abrogated in Sox9-nullFigure 8 Normal gliogenesis in the Sox9 mutant cerebellum as shown by
Robust expression of EAAT1 at E15.5 in both control and Sox9 null mutants
EAAT1 expression was found in the PCL, similar to that of BLBP. (C’-D’) The
mutants despite inactivation of Sox9. (E-F) The periventricular expression o
control and Sox9 mutant cerebella. (G-H) The normal expression of GFAP in
Bergmann glia was intact upon knockout of Sox9, as evident by the robust
found (G’-H’). Abbreviations: pcl, Purkinje cell layer; vz, ventricular zone. Scacerebellum (Figure 8A and B). At E18.5, filamentous pat-
tern of EAAT1 expression was observed in the PCL and
pial surface of both the controls and Sox9mutants, further
strengthening our initial findings that gliogenesis in cere-
bellum was not affected by the inactivation of Sox9immunofluorescence staining on cerebellar sagittal sections. (A-B)
further confirmed the intactness of radial glial scaffold. (C-D) At E18.5,
glial filaments with EAAT1 immunoreactivity were prominent in the
f S100 at the PCL also suggests the presence of astroglia in both the
the Sox9 mutant cerebellum suggested that differentiation of
distribution of GFAP especially at the PCL where Bergmann glia are
le bars: 100 μm.
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a marker for mature Bergmann glia and their precursors,
was as well not diminished in the PCL of Sox9-null cere-
bellum (Figure 8E and F). We also sought to determine
whether the terminal differentiation of Bergmann glia was
impaired upon Sox9 knockout, although this mainly oc-
curs postnatally while our mutants died shortly after birth.
The glial fibrillary acidic protein (GFAP) is a defined
marker for differentiated Bergmann glia and also white
matter fibrous astrocytes [34,35]. At E18.5, GFAP expres-
sion was seen at the PCL and some portion of the PWM
in both the control and mutants (Figure 8G, G’, H and H’),
indicating that astroglial differentiation was not defective,
at least until birth, in the Sox9-deficient cerebellum.
Discussion
Despite extensive efforts devoted to the investigations in
developmental function of SoxE family transcription fac-
tor Sox9 over the past two decades since its initial anno-
tation [36], the first studies that indicated relevant
functional roles of Sox9 for neural stem cells appeared
only recently [15,16]. Meanwhile, multiple studies have
underscored the importance of Sox9 in gliogenesis at
different CNS tissues including the retina and spinal
cord. In this study, we demonstrated that Sox9 is ro-
bustly expressed in the neural progenitors and astrocytes
of the developing cerebellum. Through the conditional
knockout of Sox9 in cerebellum, we presented evidence
that self-renewal and multipotency of cerebellar neural
progenitors did not require Sox9 while normal glial spe-
cification was not abolished. Surprisingly, our data sug-
gest that Sox9 is not critical for the aforementioned
developmental activities at the cerebellum as in else-
where of the CNS. Instead, we demonstrated an ex-
tended neurogenesis at the Sox9-null VZ during the
gliogenic period. Our study shall provide novel clues on
the diverse roles of Sox9 in neural development, which
will be crucial for understanding the cellular and mo-
lecular basis underlying the functional discrepancy of
Sox9 in different CNS tissues.
Dispensability of Sox9 in establishing and maintaining
neural stem cell identity in the cerebellum
In accordance with previous descriptions of close associ-
ation between Sox9 and Sox2/EAAT1 expression in the
retina [10], spinal cord and dorsal telencephalon of the
forebrain [16], we showed that Sox9 was first present in
cells of the cerebellar VZ neuroepithelium which display
attributes suggestive of multipotent neural progenitor
and radial glial cell (RGC) identity, as evident by coinci-
dence of Sox9 with Sox2 or EAAT1 expression throughout
the entire period of embryonic cerebellum development.
Our results therefore support that the co-expression of
Sox9 with Sox2 is a conserved feature observed across theentire developing CNS, and substantiate Sox9 as a defined
marker for neural stem cells.
Recently, it has become established that the RGCs rep-
resent the neural stem cells (NSCs) of the developing
nervous system, rather than merely a specialized type of
glial cells playing supportive and scaffolding role as were
regarded in the historical perspective [37-39]. RGCs are
also widely recognized to possess the potential for gener-
ating both neurons and glial cells [1,37]. Provided that
Sox9 has been implicated in stem cell maintenance in a
large array of tissues including the intestinal epithelium
[40], hair follicle [41], pancreas [42] as well as liver [40],
and more importantly robust expression of Sox9 in
neural progenitor pool throughout the developing CNS,
the involvement of Sox9 in the neural stem cell function
is therefore a tempting hypothesis. Indeed, a drastic loss
of proliferative progenitors and their self-renewal cap-
acity was noted in the dorsal telencephalon and spinal
cord as a consequence of inactivating Sox9 specifically at
the RGCs in the entire CNS [16]. The remnants of
neural progenitors also fail to differentiate into either
mature neurons or macroglia, reflecting the indispens-
ability of Sox9 in ensuring neural progenitor multipo-
tency. Here we attempted to ablate Sox9 with En1-Cre
and Pax2-Cre driver lines which are expressed early at
the mid-hindbrain boundary, well before the initial es-
tablishment of RGCs along the VZ neuroepithelium.
While the ablation of Sox9 in the dorsal telencephalon
interrupts the establishment of S100-expressing RGCs,
our mutants did not exhibit any defects in either the ini-
tial induction or maintenance of RGCs. Moreover, nor-
mal expression of PCNA, Ki67 and similar efficiency of
BrdU incorporation in the mutant cerebellum clearly
demonstrated that proliferative activity and self-renewal
potential of the cerebellar progenitors was not abrogated
or diminished upon Sox9 inactivation. In addition, differ-
entiated neurons of different subtypes were observed in
both the controls and Sox9 mutants, indicating no de-
fects in the developmental potential of Sox9-null cerebel-
lar progenitors. Our results thus vastly contradicts with
the current perceived model that Sox9 is a critical tran-
scription factor governing neural stem cell maintenance.
Sox9-independent astroglial specification in the
cerebellum
Since late gestation, Sox9 expression becomes restricted
to cells which are glial-committed, differentiated and
eventually colonized the PCL as prospective Bergmann
glial cells (BGs) which are the most abundant astrocytes
found specifically in the cerebellum. Provided that Sox9
is well documented to be involved in gliogenesis during
the nervous system development and is expressed per-
sistently in the cerebellar astrocytes, we examined the
glial phenotypes in our Sox9 mutants. Unexpectedly,
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EAAT1 was evident at the PCL of Sox9-null cerebellum,
suggesting that fate specification of BGs is normal in the
complete absence of Sox9 in the radial glial neural pro-
genitors. By contrast, multiple studies have demon-
strated Sox9 as a key factor determining commitment to
glial lineage at the embryonic spinal cord [12]. Sox9 is
also the master regulator triggering the switch from
neurogenesis to gliogenesis in both chick and mice by
recruiting the nuclear factor-I A [43]. Inactivation of
Sox9 in the retina led to failure in the specification and/
or differentiation of Müller glial cells, a specialized type
of astrocytes in the retina [10]. The gliogenic nature of
Sox9 is also well reflected in the manipulation of the
stem cell niche in adult brain, where overexpression of
Sox9 at the subventricular zone favors gliogenesis of
GFAP-positive astrocytes and simultaneously eliminating
neurogenesis completely [15]. With regard to our gen-
etic loss-of-function analysis in the cerebellum, our
study has therefore provided new insight on the dispens-
ability of Sox9 in gliogenesis of cerebellum, which chal-
lenge the current perception that Sox9 is the
indispensable player orchestrating neural stem cell fate
decision towards gliogenesis. There may be difference in
functional requirement of Sox9 within different tissue
types of the CNS. It is important to emphasize that here
we argue a dispensable role of Sox9 in mediating the
specification of glial fate rather than in differentiation of
BGs per se. Since the terminal differentiation of BGs
peak postnatally and that our Sox9 mutants died at birth,
the possibility that Sox9 is required for this process
should not be precluded despite normal GFAP expres-
sion in the mutant cerebellum. Being the specialized
type of cerebellar astrocytes, emerging reports are begin-
ning to propose that Bergmann glia actually represents a
cohort of adult neural stem cells in the mature cerebel-
lum [44]. Although this hypothesis still awaits substantial
evidence, previous study has indicated that Bergmann glia
expressed several SOX family transcription factors associ-
ated with stem cell maintenance including Sox1, Sox2,
Sox3 and Sox9 in the adult cerebellum [45]. Nevertheless,
inactivation of Sox9 in the cerebellum did not elicit any
abnormality in the discrete Sox2 expression within the
PCL. This suggests that the specification of BG identity is
not dependent on Sox9 function, and further strengthen-
ing our conclusion that Sox9 is dispensable for stem cell
maintenance in the cerebellum.
Sox9 can suppress neurogenesis in the cerebellum at late
gestation
During the establishment of the vertebrate CNS, neurons
are born first followed by glial cells [46]. Underlying ration-
ale for this evolutionarily conserved phenomenon is that
the position and number of neuron-supporting glial cellscan be determined by matching to the neuronal circuitry
[47]. Individual neural stem cells (or RGCs) give rise to
both neuronal and glial lineages, with the repertoire of pro-
genies changed over time [48-50]. Stem cell fate decision
between commitment to neurons or glial cells is therefore
critical, in the sense that appropriate interaction between
the neuronal circuitry and glial scaffold is a prerequisite for
proper CNS functionality [51,52]. As a corollary, failure in
generating and organizing the neurons and glia in a bal-
anced proportion is often ensued by detrimental patho-
logical conditions. For example, loss of astrocytes and their
EAAT family members may lead to excitotoxicity and is
one of the underlying causes of amyotrophic lateral scler-
osis [53]. The dysfunction of BG could cause PCs degener-
ation and contribute to spinocerebellar ataxia (SCA) 7
pathogenesis [54]. On the other hand, the uncontrolled
proliferation of glia progenitors result in highly aggressive
pediatric brain tumorigenesis [55,56]. Neural stem cell fate
determination is therefore tightly orchestrated by intricate
interplay between extrinsic environmental cues and intrin-
sic transcriptional cascades, which together first directs
neural progenitors to neurogenesis and later switches the
molecular program to gliogenesis [35]. The occurrence of
neurogenesis-to-gliogenesis switch depends on two distinct
molecular events, the cessation of neurogenesis and the ini-
tiation of gliogenesis, with the latter process better charac-
terized [43,47]. Over the past decades, several reports have
indicated Sox9 as the master transcription factor mediating
the switch to gliogenesis, specifying the glial fate choice
through interacting with requisite partner factors like NF-
1A and subsequently recruit key metabolic and migratory
genes for initiation of astro-gliogenesis [43]. In addition,
Notch1 and the JAK/STAT signaling cascade act in concert
to trigger the temporal transition to gliogenesis by transac-
tivating promoter of the glial-specific gene Gfap [47]. Con-
versely, molecular machinery that inhibits neurogenesis
during the gliogenic phase remains largely elusive. Having
observed that the number of VZ-derived neuronal subtypes
increased remarkably only after E16.5 in the Sox9 inacti-
vated cerebellum, we suggest that this is due to a failure in
the suppression of neuronal production at the VZ after the
onset of gliogenesis. As discussed before, GABAergic inter-
neurons are generated from specified progenitors in the
prospective white matter (PWM) since late gestation. One
may therefore argues that increased neurogenesis occurs at
this secondary germinal site rather than within the neural
progenitor pool at the VZ. While certainly possible, we be-
lieve that this is unlikely the case since we did not observe
any increase in BrdU incorporation rate at the PWM since
E16.5. Importantly, significant increase in the number of
Pax2-expressing interneurons born at E16.5 was noticed in
our Sox9 mutants, suggesting the production of GABAer-
igc interneurons outside the PWM at late gestation. We
also examined whether increased neurogenesis occur at a
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Since no significant difference in the number of Pax2-
expressing cells born at E13.5 between control and Sox9-
null cerebellum was observed, this strongly supports that
the surplus of GABAergic interneurons were born at
E16.5 or thereafter. Taken together, our results indicate
that Sox9 inactivation in the cerebellum has elicited a
prolonged period of neurogenesis at the VZ, which ex-
tended way beyond the normal neurogenic period and
into the gliogenic phase. Our results therefore suggest
Sox9 can promote the progression of neuron-to-glial
switch in cerebellum by suppressing the neural progen-
itors from adopting a neurogenic program. Indeed,
various studies have demonstrated that while the
neural progenitor pool becomes more biased to glial
commitment as development proceeds, their neuro-
genic capacity is retained intrinsically [57,58], suggest-
ing some molecular mechanisms must counteract the
neurogenic capacity of the neural progenitors thereby
prevent neurogenesis from occuring. Interestingly, the
up-regulation of Ngn2 expression at E16.5 probably
reflects the abnormal neurogenic potential in Sox9-
null neural progenitors after the neuron-glia switch.
Notably, neurogenesis was extended at the expense of
gliogenesis in the Sox9-ablated spinal cord. By con-
trast, gliogenesis proceeds normally in the cerebellum
despite compromised suppression of neurogenesis in
the absence of Sox9. Hence, we believe that the pri-
mary functional role of Sox9 in modulating the
neuron-versus-glia switch is to suppress the neuro-
genic program of the neural progenitors, rather than
actively triggering the onset of gliogenesis. In support
of this view, overexpression of Sox9 in the adult sub-
ventricular zone (SVZ) cells completely abolished
neuronal production, while the suppression of which
by miR-124 is a critical step in promoting neurogen-
esis at the adult glial stem cell niche [15]. In contrast
to this view are the previous findings showing Sox9 is
the master regulator for gliogenesis and actively pro-
motes glial lineage progression. It was proposed that
Sox9 facilitates gliogenesis in a feedforward mechan-
ism, by inducing NFIA expression and subsequently
associates with the transcription factor, which together
activates glial-specific genes [43]. However, normal
glial specification in our mutants suggested that Sox9
is not absolutely critical for the formation of such a
gliogenic-transcriptional complex. Since the inactiva-
tion of Sox9 impaired the termination of neurogenesis
in the entire CNS, Sox9 is probably an instructive cue
for timing of neurogenesis. On the basis of this pri-
mary function, Sox9 also acts as a permissive factor
for the onset of gliogenic program however, of which
the importance and requirement of Sox9 may be tissue/
organ dependent. Taken together, our study provides novelevidence on the primary functional roles of Sox9 during
neuron-glia fate switch in cerebellum, while challenges the
current view of Sox9 as the key initiating factor for glio-
genesis in CNS.Conclusion
Sox9 is dispensable for neural stem cell induction, mainten-
ance and multipotency in the cerebellum. Our results indi-
cate that Sox9 mediate the neuron-to-glia fate switch by
modulating the termination of neurogenesis, but not the
initiation of gliogenesis as in other CNS compartments.
Methods
Generation of conditional knockout mice
The generation and genotyping of conditional (floxed)
Sox9 (Sox9fx/fx) mouse line [59], En1Cre [23], Pax2Cre
mouse line [22] and ROSA26R reporter mouse line [60]
have been described previously. To generate conditional
cerebellum specific Sox9 knockout mutant, we crossed
heterozygous either En1Cre or Pax2Cre mice with homo-
zygous Sox9fx/fx mice to generate En1Cre/+; Sox9fx/+ or
Pax2Cre/+; Sox9fx/+ males. To obtain En1Cre/+; Sox9fx/fx or
Pax2Cre/+; Sox9fx/fx mutant embryos for analysis, Sox9fx/fx
females were then crossed with either En1Cre/+; Sox9fx/+
or Pax2Cre/+; Sox9fx/+ males. Their respective Sox9 het-
erozygous littermates with Cre allele, which developed
normally, were used as controls. Since the pedigrees
have been maintained by intercross breeding, the mouse
genetic background is a mixture of C57BL/6 J, CD-1 and
129/Sv strains. Crosses were established and noon of the
day when a vaginal plug was identified was designated as
embryonic day (E) 0.5, while the day of birth was desig-
nated as postnatal day (P) 0. Mice bearing the wild-type,
floxed and conditional null Sox9 alleles, as well as the
Cre and ROSA26 reporter alleles were determined by
PCR analyses using DNA extracted from the tails or yolk
sac tissues as described previously [61]. At least three
embryos for each genotype were examined in the experi-
ments described below and embryos from the same litter
were used for comparisons between the mutant and
control. All animal procedures were conducted with the
approval of the Animal Experimentation Ethics Commit-
tee of The Chinese University of Hong Kong.
X-gal staining
E9.5 embryos were harvested in ice-cold PBS and fixed
in freshly prepared 4% (w/v) paraformaldehyde (PFA) in
PBS for 15 minutes at 4°C. After fixation, embryos were
rinsed three times with Rinse Buffer [0.02% (v/v) NP40;
0.01% (v/v) deoxycholate; PBS] for 15 minutes at room
temperature and then stained with Staining Solution
[5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6; 0.02% (v/v) NP40;
0.01% (v/v) deoxycholate; 2 mM MgCl2; 5 mM EGTA;
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staining, embryos were post-fixed with 4% PFA in PBS at
4°C overnight.
Immunohistochemistry
Timed-pregnant mice were sacrificed and the uterine horns
were removed. Dissected brains from embryos were fixed
in 4% (w/v) PFA in PBS at 4°C overnight. Fixed tissues were
then dehydrated through an ethanol series, paraffin-
embedded and sectioned at 7 μm thickness. For general
histological examination, sections were mounted on Super-
frost® Plus slides (Thermo Scientific) and stained with
hematoxylin and eosin. For immunofluorescence staining,
deparaffinized sections were subjected to antigen retrieval
with heating in 10 mM sodium citrate buffer (pH 6.0) by
microwave. Sections were blocked in 10% horse serum, in-
cubated in primary and secondary antibodies for overnight
at 4°C and 1 h at room temperature respectively. Nuclei
were counterstained with Hoechst 33342 (1:1000, Molecu-
lar Probes). Sections were mounted in ProLong® Gold anti-
fade reagent (Molecular Probes). For cryosections, brains
were isolated from fetal mice and fixed in 4% PFA in PBS
for 2 hours at 4°C. Tissues were then washed several times
in PBS and cryoprotected in 20% (w/v), followed by 30%
(w/v) sucrose in PBS and Tissue-Tek® OCTTM compound
(Sakura) for 1 night each at 4°C. The brains were then em-
bedded in OCT medium in liquid nitrogen and stored at
−80°C prior to sectioning. Tissues were sectioned at 10 μm
thickness and stained as described above. Pictures were
taken using either epifluorescence microscope equipped
with a CCD camera (DP72; Olympus) or confocal scanning
microscope (FV1000, Olympus).
RNA extraction, reverse transcription and real-time PCR
Total RNAs were extracted from E18.5 cerebellum using
TRIzol reagent (Invitrogen) following the manufacturer’s
protocol. Reverse transcription was performed with 2 μg
of extracted RNAs using the SuperScript III First-Strand
Synthesis System (Invitrogen). Quantitative real-time
PCR was performed with QuantiFast SYBR Green PCR
Kit (Qiagen), transcript expression level was analyzed in
triplicates using the comparative cycle time (Ct) method
and normalized with β-actin. Experimentally validated
primers were adopted from PrimerBank [62] unless spe-
cified otherwise. Primers targeting Sox8, Sox9 and Sox10
were described previously [63]. Primers for β-actin were
as follows: 5′-TAA AGA CCT CTA TGC CAA CAC
AGT-3′; 5′-CAC GAT GGA GGG GCC GGA CTC
ATC-3′.
Bromodeoxyuridine incorporation assay
Pregnant mice were injected intraperitoneally twice at
30-minute intervals with bromodeoxyuridine (BrdU) dis-
solved in sterile saline at 100 μg/g body weight and thensacrificed 30 min after injection. For BrdU tracing exper-
iments, injections were performed as described at E13.5
or E16.5 and embryos were harvested at E18.5. Embryos
were fixed in 4% (w/v) PFA in PBS at 4°C overnight, em-
bedded in paraffin and sectioned at 7 μm thickness.
BrdU-labelled cells were revealed by immunostaining
with anti-BrdU antibody as described above.Quantification of proliferating cells, cell count
experiments and statistical analysis
Quantitative analysis of proliferating cells in the cerebel-
lum were conducted by counting at least 10 alternative
parasagittal paraffin sections (7 μm) from the cerebellar
vermis to obtain the average labeling indices. To esti-
mate the labeling indices at the VZ, the number of BrdU
positive cells was divided by the total number of VZ
cells for each section. To quantify proliferative cells in
the prospective white matter, the number of BrdU
immunoreactive cells was divided by the area of cerebel-
lum analyzed using the ImageJ software version 1.46r
(http://rsb.info.nih.gov/ij/). Quantifications for Purkinje
cells and interneurons were performed by counting all
Foxp2+ and Pax2+ cells in 10 equally spaced alternative
sections from the cerebellar vermis. Statistical analyses
for all cell count experiments were conducted using the
GraphPad Prism 5 software (GraphPad Software Inc.,
San Diego, CA, USA). Data were expressed as means ±
SEM. Student’s t-test was employed for group compari-
sons. Calculated p-values of less than 0.05 (p < 0.05)
were considered as statistically significant.Antibodies
Primary antibodies and dilutions used were as follows:
rabbit anti-BLBP (1:500, Millipore ABN14); rat anti-
BrdU (1:70, Abcam ab6326); rabbit anti-Calbindin D-
28K (1:250, Millipore AB1178); rabbit anti-cleaved
caspase-3 (1:200, Cell Signaling Technology 9664); rabbit
anti-EAAT1 (GLAST; 1:250, Abcam ab416); rabbit anti-
Foxp2 (1:1000, Abcam ab16046); rabbit anti-Ki67 (1:100;
Millipore AB9260), rabbit anti-Lim-1 (Lhx1; 1:100, Milli-
pore AB3200); rabbit anti-Pax2 (1:500, Invitrogen 71–
6000); rabbit anti-Pax6 (1:1000, Millipore AB2237);
mouse anti-PCNA (1:200, Thermo Scientific MA5-
11358); rabbit anti-Sox2 (1:200, Millipore AB5603);
rabbit anti-Sox9 (1:2000, Millipore AB5535); goat anti-
hSox9 (1:200, R&D Systems AF3075); goat anti-Sox10
(1:50, Santa Cruz sc-17342). For the secondary anti-
bodies, HRP-conjugated affinity-purified goat anti-rabbit
(Millipore AP132P) or anti-mouse IgG (Millipore
AP308P) were used at a dilution of 1:250. Alexa Fluor®-
conjugated secondary antibodies (Invitrogen A21245,
A11024, A11055) were used at 1:1000.
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